| View |
|
DRP-13862-01
|
Paracetamol
|
Fevint
|
150 mg / mL
|
Solution for Injection (IM/IV)
|
Analgesic / Antipyretic
|
Makcur Laboratories Limited
|
India
|
CLIDP Conversion
|
21 July 2024
|
04 May 2028
|
| View |
|
DRP-14088-09
|
Tobramycin (as sulfate) + Dexamethasone (as sodium phosphate)
|
Zartob DM
|
3 mg/1 mg (0.3%/0.1% w/v) per mL
|
Sterile Ophthalmic Suspension (Eye Drops)
|
Antibacterial (Aminoglycoside) / Corticosteroid
|
Makcur Laboratories Limited
|
India
|
CLIDP Conversion
|
21 July 2024
|
20 June 2028
|
| View |
|
DRP-14278-03
|
Montelukast (as sodium) + Levocetirizine dihydrochloride
|
Montezel
|
10 mg / 5 mg
|
Film-Coated Tablet
|
Leukotriene Receptor Antagonist / Antihistamine (Piperazine Derivative)
|
Magbro Healthcare Pvt. Ltd.
|
India
|
CLIDP Conversion
|
21 July 2024
|
09 August 2028
|
| View |
|
DRP-14803-01
|
Ketoconazole
|
Gonazol
|
20 mg/g (2% w/w)
|
Cream
|
Antifungal
|
S Kant Healthcare Ltd.
|
India
|
CLIDP Conversion
|
21 July 2024
|
11 January 2029
|
| View |
|
BRP-100-12
|
Epoetin Alfa
|
Epson 4000IU
|
4000 IU/mL
|
Solution for Injection (IV/SC)
|
Antianemic Preparations
|
Shenyang Sunshine Pharmaceutical Co., Ltd.
|
China
|
CLIDP Conversion
|
20 July 2024
|
14 December 2026
|
| View |
|
DRP-737-02
|
Ambroxol Hydrochloride
|
Novoxin
|
15 mg/5 mL
|
Syrup
|
Mucolytic
|
Lifesquare Laboratories Inc
|
Philippines
|
CLIDP Conversion
|
20 July 2024
|
10 April 2029
|
| View |
|
DRP-2373-05
|
Folic Acid
|
Anebloc
|
5 mg
|
Capsule
|
Vitamin/Hematinic
|
LIFESQUARE LABORATORIES INC.
|
Philippines
|
CLIDP Conversion
|
20 July 2024
|
26 May 2029
|
| View |
|
DRP-5046-04
|
Zoledronic Acid (as zoledronic anhydrous)
|
ZolHealth 4
|
4 mg
|
Lyophilized powder for Injection (IV)
|
Bisphosphonate
|
Admac Lifesciences
|
India
|
CLIDP Conversion
|
20 July 2024
|
13 August 2027
|
| View |
|
DRP-5362-29
|
Acetylcysteine
|
Meducil-A
|
600 mg
|
Powder for Oral Solution
|
Mucolytic
|
Unicure Remedies Pvt. Ltd.
|
India
|
CLIDP Conversion
|
20 July 2024
|
25 June 2029
|
| View |
|
DRP-7742-11
|
Multivitamins + Mineral + Buclizine
|
Buclikids
|
(see formulation on reverse side)
|
Syrup
|
Vitamins/Appetite Stimulant
|
Lloyd Laboratories, Inc.
|
Philippines
|
CLIDP Conversion
|
20 July 2024
|
05 September 2029
|
| View |
|
DRP-10512-14
|
Febuxostat
|
Noric 40
|
40 mg
|
Film-Coated Tablet
|
Antigout
|
Stallion Laboratories Pvt. Ltd
|
India
|
CLIDP Conversion
|
20 July 2024
|
07 October 2026
|
| View |
|
DRP-10604-06
|
Levodropropizine
|
Neumodrop
|
30 mg/ 5 mL
|
Syrup
|
Cough Supressant
|
Lloyd Laboratories, Inc.
|
Philippines
|
CLIDP Conversion
|
20 July 2024
|
22 October 2026
|
| View |
|
DRP-11525-01
|
Levofloxacin
|
Goflox 500
|
500 mg
|
Film-Coated Tablet
|
Antibacterial (Fluoroquinolone)
|
Ratnatris Pharmaceuticals Private Limited
|
India
|
CLIDP Conversion
|
20 July 2024
|
31 March 2027
|
| View |
|
DRP-11851-11
|
Montelukast (as sodium) + Levocetirizine Hydrochloride
|
Montledual
|
10 mg/ 5 mg
|
Film-Coated Tablet
|
Leukotriene Receptor Antagonist/Antihistamine
|
Cooper Pharma Limited
|
India
|
CLIDP Conversion
|
20 July 2024
|
10 May 2027
|
| View |
|
DRP-12430-03
|
Montelukast (as sodium) + Levocetirizine Hydrochloride
|
Retair
|
10 mg / 5 mg
|
Film-Coated Tablet
|
Leukotriene Receptor Antagonist / Antihistamine
|
Indchemie Health Specialities Pvt. Ltd.
|
India
|
CLIDP Conversion
|
20 July 2024
|
05 August 2027
|
| View |
|
DRP-13027-01
|
Vildagliptin
|
Vildasure
|
50 mg
|
Tablet
|
Hypoglycemic Agent [Dipeptidyl Peptidase-4 (DPP-4) Inhibitor]
|
Lee Pharma Limited
|
India
|
CLIDP Conversion
|
20 July 2024
|
18 November 2027
|
| View |
|
DRP-13048-05
|
Salbutamol (as sulfate) + Ipratropium bromide
|
Ipsa-Duo
|
2.5 mg/500 mcg per 2.5 mL
|
Solution for Inhalation
|
Selective beta-2-adrenoreceptor agonist/Anticholinergic
|
Ahlcon Parenterals (India) Limited
|
India
|
CLIDP Conversion
|
20 July 2024
|
24 November 2027
|
| View |
|
DRP-13704-02
|
Betahistine hydrochloride
|
Verzen 16
|
16 mg
|
Tablet
|
Antivertigo preparation
|
Magbro Healthcare Pvt. Ltd.
|
India
|
CLIDP Conversion
|
20 July 2024
|
29 March 2028
|
| View |
|
DRP-13706-03
|
Betahistine hydrochloride
|
Verzen 24
|
24 mg
|
Tablet
|
Antivertigo preparation
|
Magbro Healthcare Pvt. Ltd.
|
India
|
CLIDP Conversion
|
20 July 2024
|
29 March 2028
|
| View |
|
DRP-14389-01
|
Furosemide
|
Furovint
|
10 mg / mL (20 mg / 2 mL)
|
Solution for Injection (I.V./I.M.)
|
Diuretic (Sulfonamide)
|
Makcur Laboratories Limited
|
India
|
CLIDP Conversion
|
20 July 2024
|
31 August 2028
|